Pharma & Biotech - Page 18

Johnson and Johnson has now delivered five consecutive quarters of at least 6% revenue growth, demonstrating remarkable resilience in the face of significant headwinds. The pharmaceutical giant’s immunology portfolio absorbed a serious

Gilead Sciences Canada has taken home a Bronze Lion at Cannes for its creative HIV prevention campaign built around LGBTQIA+ community identity. The campaign, titled Animal Attraction, was developed in partnership with

Merck has secured FDA approval for Lipfendra, its internally developed cholesterol-lowering drug, marking a significant milestone in cardiovascular medicine. Lipfendra, known scientifically as enlicitide, is a macrocyclic peptide that becomes the first

CG Life and its 24/364 platform have officially launched the inaugural 24/364 Rare Disease Film Festival, a first-of-its-kind cultural event dedicated to rare disease storytelling. The festival aims to amplify the voices

Novo Nordisk and biosimilar developer Alvotech are both contending with renewed regulatory pressure over manufacturing practices at facilities with troubled inspection histories. The U.S. Food and Drug Administration this week disclosed concerns

Novartis has secured traditional FDA approval for Fabhalta, also known as iptacopan, to slow kidney function decline in adults with primary immunoglobulin A nephropathy. The approval targets adults with IgAN who are

Germany’s sweeping health insurance overhaul is colliding with a US Section 301 trade investigation, creating mounting pressure across global pharmaceutical supply chains. A fixed 15.5% manufacturer rebate on patented branded drugs has

Foundation Medicine has announced a new initiative designed to raise awareness about the critical role of quality and accuracy in cancer biomarker testing. The Quality First initiative centres on patient advocate stories

Pharmaceutical companies are losing commercial momentum at a critical moment in the patient journey, according to a new analysis by Flora Health’s chief growth officer. Karina Castagna argues that most practical barriers

Vanda Pharmaceuticals (Nasdaq: VNDA) has announced a sponsorship deal placing its NEREUS brand on Mick Schumacher’s No. 47 car in the NTT IndyCar Series. The pharmaceutical firm will serve as primary sponsor